Fluaid

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of sore throat.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

For adults and children aged 12 years and older, the recommended dosage is to place one bag in 6 ounces of boiling water and stir until dissolved. The liquid should be allowed to cool before consumption. Patients may drink this preparation up to four times daily, or as directed by a healthcare professional.

For children under 12 years of age, it is advised to consult a doctor for appropriate dosing recommendations.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to adhere strictly to the recommended usage guidelines. The product should not be used otherwise than as directed, and the recommended dosage should not be exceeded to ensure safety and efficacy.

Warnings and Precautions

In the event of an accidental overdose, it is imperative to seek professional assistance or contact a poison control center immediately to ensure appropriate management and care.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following conditions occur:

• A sore throat that is severe, persists for more than two days, or is accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting.

• Symptoms of a sore mouth that do not show improvement within seven days.

• Any irritation, pain, or redness that persists or worsens.

These precautions are essential to ensure patient safety and to facilitate timely medical intervention when necessary.

Side Effects

In the event of an accidental overdose, patients are advised to seek professional assistance or contact a poison control center immediately.

Patients should discontinue use and consult a healthcare professional if they experience any of the following: severe sore throat that persists for more than 2 days, sore throat accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting; sore mouth symptoms that do not improve within 7 days; or if irritation, pain, or redness persists or worsens. These symptoms may indicate a more serious condition requiring medical evaluation.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Fluaid (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should consult a healthcare professional before use. The safety and efficacy of this medication in this age group have not been established, and specific dosing recommendations are not provided for children in this category. Caution is advised when considering treatment for pediatric patients.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and maternal health. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Renal impairment may necessitate dosage adjustments for patients with reduced kidney function. It is important to monitor renal function tests regularly in these patients to ensure safety and efficacy. A reduced dose should be considered for patients with decreased creatinine clearance. Additionally, special monitoring is required for patients with significant renal impairment to manage potential risks effectively.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an accidental overdose, it is imperative to seek professional assistance without delay. Healthcare professionals should contact a poison control center immediately to obtain guidance on the appropriate management of the situation.

Symptoms of overdose may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential. Prompt recognition of symptoms can facilitate timely intervention and improve patient outcomes.

Management procedures should be initiated based on the recommendations provided by the poison control center. This may include supportive care, monitoring of vital signs, and symptomatic treatment as necessary. It is crucial for healthcare providers to remain vigilant and act swiftly to mitigate the potential risks associated with an overdose.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of reach of children to prevent accidental ingestion. Patients should be instructed to use the product only as directed and to avoid exceeding the recommended dosage.

Providers should inform patients to discontinue use and seek medical advice if they experience any of the following: a severe sore throat that persists for more than two days; a sore throat accompanied or followed by fever, headache, rash, swelling, nausea, or vomiting; sore mouth symptoms that do not improve within seven days; or if irritation, pain, or redness persists or worsens.

Storage and Handling

The product is supplied in a tightly closed container to ensure its integrity. It should be stored at room temperature, away from direct light exposure. To maintain safety, it is essential to keep the product out of reach of children. Any unused product should be discarded after opening to prevent potential risks associated with prolonged exposure.

Additional Clinical Information

The medication is administered orally. For adults and children aged 12 years and older, the recommended method involves placing one bag in 6 ounces of boiling water, stirring, and allowing the liquid to cool before consumption. Patients may drink this preparation up to four times daily or as directed by a healthcare provider. For children under 12 years of age, it is advised to consult a doctor before use.

Clinicians should counsel patients to seek advice from a health professional if they are pregnant or breastfeeding. It is important to keep this and all medications out of the reach of children and to use the product only as directed. In the event of an accidental overdose, patients should seek professional assistance or contact a poison control center immediately.

Drug Information (PDF)

This file contains official product information for Fluaid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)